SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Singh Seema)
 

Search: WFRF:(Singh Seema) > (2020-2024) > Prescription Practi...

  • Prasad, N. (author)

Prescription Practices in Patients With Mild to Moderate CKD in India

  • Article/chapterEnglish2021

Publisher, publication year, extent ...

  • Elsevier BV,2021

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/309155
  • https://gup.ub.gu.se/publication/309155URI
  • https://doi.org/10.1016/j.ekir.2021.06.011DOI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Introduction: Patients with chronic kidney disease (CKD) require multiple medications. There is no information on prescription patterns or the use of evidence-based therapies for management of CKD from low-middle-income countries. Using baseline data from the Indian CKD (ICKD) cohort, we describe the drug prescription practices in patients with mild to moderate CKD. Methods: The ICKD study is a prospective, observational cohort study of mild to moderate kidney disease across 11 centers in India. We analyzed all the prescriptions captured at enrollment in the ICKD study. Drugs were categorized into 11 different groups. We provide descriptive data on prescription details and evaluate the appropriateness of medication use. Results: Complete prescription data were available in 3966 out of 4056 (97.8%) subjects enrolled in the ICKD database. Most patients had stage 3 CKD, 24.9% had diabetic kidney disease, 87% had hypertension, and 25.5% had moderate to severe proteinuria. Renin-angiotensin-aldosterone system blockers were prescribed in less than half (47.9%) and in 58.8% of patients with proteinuric CKD. Metformin was prescribed in 25.7% of diabetic subjects with CKD. Only 40.4% of patients were taking statins; 31.1% and 2.8% subjects with anemia were receiving iron and erythropoiesis-stimulating agents, respectively. Conclusion: This study highlights the missed opportunities for improving outcomes through appropriate prescriptions of drugs in patients with CKD. There is need for dissemination of evidence-based guidelines and institution of sustainable implementation practices for improving the overall health of patients with CKD. © 2021 International Society of Nephrology

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Yadav, A. K. (author)
  • Kundu, M. (author)
  • Sethi, J. (author)
  • Jaryal, A. (author)
  • Sircar, D. (author)
  • Modi, G. K. (author)
  • Kamboj, K. (author)
  • Sahay, M. (author)
  • Gopalakrishnan, N. (author)
  • Kaur, P. (author)
  • Vikrant, S. (author)
  • Varughese, S. (author)
  • Baid-Agrawal, Seema,1966Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för kirurgi,Institute of Clinical Sciences, Department of Surgery(Swepub:gu)xbaise (author)
  • Singh, S. (author)
  • Gang, S. (author)
  • Parameswaran, S. (author)
  • Kumar, V. (author)
  • Ghosh, A. (author)
  • Jha, V. (author)
  • Göteborgs universitetInstitutionen för kliniska vetenskaper, Avdelningen för kirurgi (creator_code:org_t)

Related titles

  • In:Kidney International Reports: Elsevier BV6:9, s. 2455-24622468-0249

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view